Search by Drug Name or NDC
NDC 17156-0235-01 AdreView 2 mCi/mL Details
AdreView 2 mCi/mL
AdreView is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medi-Physics Inc.. The primary component is IOBENGUANE I-123.
Product Information
NDC | 17156-0235 |
---|---|
Product ID | 17156-235_44cadee9-19ca-4756-ab85-0836b38db89f |
Associated GPIs | 94354050102020 |
GCN Sequence Number | 068315 |
GCN Sequence Number Description | iobenguane sulfate I-123 VIAL 10 MCI/5ML INTRAVEN |
HIC3 | P5F |
HIC3 Description | ADRENAL RADIOACTIVE DIAGNOSTICS |
GCN | 31077 |
HICL Sequence Number | 038326 |
HICL Sequence Number Description | IOBENGUANE SULFATE I-123 |
Brand/Generic | Brand |
Proprietary Name | AdreView |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Iobenguane I-123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | mCi/mL |
Substance Name | IOBENGUANE I-123 |
Labeler Name | Medi-Physics Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA022290 |
Listing Certified Through | 2025-12-31 |
Package
NDC 17156-0235-01 (17156023501)
NDC Package Code | 17156-235-01 |
---|---|
Billing NDC | 17156023501 |
Package | 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS |
Marketing Start Date | 2008-09-19 |
NDC Exclude Flag | N |
Pricing Information | N/A |